Cannabis Law Report

JUNE 14, 2022

Ketamine is already registered for the treatment of depression and in 2023, the FDA might approve an MDMA assisted therapy for PTSD. Psychedelic compounds – such as psilocybin and MDMA – are one such extremely promising area. The field of psychedelic science is moving forward at a rapid pace.

Access 52

Access Therapy Clinical Trials Treatment 52

Canna Law Blog

AUGUST 8, 2023

The deadline for RFI responses is August 18, 2023. The Farm Bill is renewed every five years, so policymakers are ramping up for the 2023 version on pertinent topics– including CBD and other hemp-derived cannabinoids. How should a new framework for CBD products balance consumer safety with consumer access?

CBD 68

CBD Topical Food Cannabinoids 68

Project CBD

JULY 28, 2023

Project CBD: Your presentation with Allyn Howlett at the International Cannabinoid Research Society conference in Toronto (June 2023) discussed the chemical conversion of CBD into Δ8-THC (delta-8 THC) and “numerous additional THC isomers. with unknown pharmacological and safety profiles.”

THC 212

THC Cannabinoids Hemp Research and Development 212

Canna Law Blog

JANUARY 26, 2023

As of January 26, 2023, the FDA concluded that it will NOT regulate CBD foods or dietary supplements. In addition, a new pathway could provide access and oversight for certain CBD-containing products for animals. A new regulatory pathway could provide access and oversight for certain CBD-containing products for animals.

Food 81

Food CBD Safety Legislation 81

Cannabis Law Report

JULY 1, 2022

Move cannabis excise-tax collection and remittance to retail in 2023, establishing one point of collection and remittance and greatly simplifying tax requirements for the entire cannabis supply chain. You can access the bill language here.

Supply Chain 52

Supply Chain Legislation Collective Retail 52

Cannabis Law Report

FEBRUARY 28, 2022

The Board is made up of people who were appointed by the governor to create recommendations for the rules for the state’s legal psilocybin services, which begin in January 2023.

Research and Development 105

Research and Development Safety Policy Conditions 105

Cannabis Law Report

MAY 16, 2022

Gavin Newsom introduced proposed revisions to his 2022-2023 budget proposal, which would eliminate the cannabis cultivation tax rate beginning July 1, 2022. The 15% excise tax on cannabis sales would remain, and the collection and remittance of that tax would be limited to retail sales beginning January 1, 2023.

Legalization 52

Legalization Collective Education Cultivation 52

Veriheal

JUNE 1, 2023

It had passed through the Senate and the Public Safety and Health committees, but the Assembly Appropriations Committee gutted its main provisions. Thus, Weiner pulled it out from consideration until 2023. voters are in favor of legal access to psychedelics treatment. because there is no public hearing.”

Legalization 76

Legalization Decriminalization Legislation Therapy 76

Peninsula Alternative Health

MARCH 22, 2023

Effective July of 2023, the new legislation aims to regulate medical and recreational cannabis as similarly as possible, holding them to the same standards. Additionally, everything will be tracked from seed to sale as it is now, ensuring that consumers can have confidence in the quality and safety of the product they are buying.

Patients 98

Patients Legalization Seed-To-Sale Dispensary 98

MMJ Recs

JANUARY 20, 2024

The state’s thoughtful approach seeks to ensure that those with genuine medical needs have access to this alternative treatment while maintaining a balance between patient care and preventing misuse. These dispensaries, regulated by the Maryland Cannabis Administration, serve as the primary outlets for medical cannabis products.

Law 52

Law Marijuana Patients Chronic Pain 52

MMJ Recs

DECEMBER 13, 2023

Let’s take a look at the current state of medical marijuana dispensaries in Texas, examining the legal framework, patient access, and the potential impact on the healthcare landscape. These dispensaries operate under strict regulations and oversight to ensure the safety and well-being of patients.

Dispensary 52

Dispensary Patients Marijuana Epilepsy 52

Veriheal

MAY 30, 2023

A new 2023 study published in BMJ Supportive & Palliative Care suggests that cannabis could be the answer millions of cancer patients have been looking for. The study established that medicinal cannabis had an acceptable safety profile, with only 15 adverse reactions occurring among 11 patients, most of which could be classified as minor.

Medicine 96

Medicine Treatment Patients Data 96

The Cannigma

AUGUST 9, 2023

Because the process of producing these cannabinoids from hemp is not simple chemistry, scientists have raised concerns about the safety of these processes, and the byproducts that are produced while converting CBD into THC. 6 What about unregulated cannabis edibles? Store cannabis in a secure, lockable device.

Packaging 77

Packaging Edibles Wellness and Beauty Blood Pressure 77

Peninsula Alternative Health

MARCH 22, 2023

Effective July of 2023, the new legislation aims to regulate medical and recreational cannabis as similarly as possible, holding them to the same standards. Additionally, everything will be tracked from seed to sale as it is now, ensuring that consumers can have confidence in the quality and safety of the product they are buying.

Patients 52

Patients Legalization Seed-To-Sale Marijuana 52

MMJ Recs

OCTOBER 5, 2023

These laws are designed to protect patients, provide access to treatment, and prevent abuse. Licensed cultivators and processors are held to strict standards to ensure the quality and safety of medical cannabis products. Registered patients can renew their cards annually to continue accessing medical cannabis.

Dispensary 52

Dispensary Patients Treatment Conditions 52

Canna Law Blog

DECEMBER 19, 2022

Safety and accessibility concerns were at the fore. For anyone who does, or wants to advocate for the ongoing right to offer drive-thru and delivery sales as currently allowed, stay tuned for the separate rulemaking process OLCC now proposes in 2023. Proposed OAR 845-025-1300.

Retail 71

Retail Packaging Compliance Compliance 71

Veriheal

MARCH 31, 2023

While the study’s findings are promising, researchers say that more studies are necessary to evaluate the efficacy and safety of these cannabis treatments. Fast-forward to 2023, and the state has now granted the first of these psilocybin manufacturing licenses to Satori Farms PDX LLC. Let us know in the comments!

Legalization 52

Legalization Chronic Pain Decriminalization Patients 52

Canna Law Blog

MARCH 17, 2023

11 Meanwhile, thousands of illicit retailers are selling unregulated, untested, and untaxed cannabis products of questionable origin and dubious safety across the State. Here comes more New York cannabis program litigation. Thus, as of this writing, only four licensed adult-use retail dispensaries are open in the entire State of New York.11

Retail 73

Retail Dispensary Programs Cannabis 73

Project CBD

APRIL 11, 2023

In February 2023, Project CBD published a story about Curaleaf , the scandal-ridden, multistate and multinational company, which has achieved a leading position in the U.S. Recommended Readings The post Downstream Effects: April 2023 appeared first on Project CBD. Department of Agriculture.” ” © Copyright, Project CBD.

Supply Chain 146

Supply Chain Environment CBD Cultivation 146

Veriheal

MARCH 1, 2022

The campaign manager of the ‘Yes on 109’ campaign that helped see the measure passed, Sam Chapman, told media sources, “There’s a huge breadth of expertise on this board from harm reduction experts to folks that have experience working with different populations that stand to benefit from having access to psilocybin therapy.

Therapy 98

Therapy Programs Microdosing Medicine 98

Canna Law Blog

JULY 14, 2023

On July 5, 2023, the FDA and FTC jointly announced six cease and desist letters to alleged delta-8 product makers. You can access the letters here. Unlike prior rounds of warning letters, these letters have a new focus: harm to children. Ingesting edible cannabis products can result in serious health consequences in children.3

Packaging 74

Packaging Food Edibles THC 74

Canna Law Blog

FEBRUARY 3, 2020

Europe has also witnessed a huge demand for the most coveted cannabinoid, whose market, Brightfiled Group predicts, will grow by 400% by 2023. According to BDS Analytics and Arcview Market Research , the CBD market is expected to surpass $20 billion by 2024 in the United States alone. Unlike the U.S.

CBD 85

CBD Food Hemp Cannabinoids 85

The Blunt Truth

MAY 30, 2023

We also commented on the potential casual use of cannabis in the workplace, with some co-working environments expanding access to alcohol and more. Effective federal measures to ensure public safety. Indeed, on May 23, 2023, WSWA hosted a panel on the subject, where lawmakers reportedly urged bipartisan cooperation on the issue.

History 96

History Cannabis Legalization Environment 96

Cannabis Law Report

DECEMBER 16, 2021

In November 2020, Oregon voters passed Measure 109, which creates a state-sanctioned program enabling adults over the age of 21 to access lab-tested psilocybin in a controlled setting, under the supervision of a licensed facilitator. So what will the legal Oregon psilocybin industry look like? Learning Measure 109.

Business 52

Business Programs Access Concentrates 52

Veriheal

JUNE 10, 2022

Those not covered under the CEPAA include police, security guards, construction workers, those who operate heavy machinery, and others in “safety-sensitive” occupations. To assist these individuals, Illinois recently established an initiative to them gain access to legal aid and other resources needed to expunge their records.

Edibles 79

Edibles Law Consumption Cannabis 79

Medicinal Genomics

JANUARY 10, 2024

Since then, CannMed has transformed into an industry event that attracts the brightest minds in cannabis science, medicine, cultivation, and safety testing. In 2023, CannMed transformed into an Innovation and Investment Summit held at the J.W. Marriott Marco Island Beach Resort, Marco Island, FL.

Research and Development 52

Research and Development Events Education Medicine 52

Cannabis Law Report

APRIL 21, 2022

Publication of this process establishes “prior art,” contributing to MAPS’ patient access strategy by making intellectual property public . As we approach our anticipated FDA approval in 2023, the availability of cGMP-compliant MDMA will be secured for future therapeutic use. Berra Yazar-Klosinski, Ph.D.

Clinical Trials 52

Clinical Trials Research and Development Therapy Media 52

NORML

MARCH 22, 2019

Legislation is pending, Senate Bill 59, to expand medical cannabis access. Update : HB 1383 was heard and approved by the Committees on Judiciary and Public Safety, Intergovernmental, and Military Affairs on 3/19. Legislation is pending, House Bill 673 / Senate Bill 1430, to expand medical cannabis access. DE resident?

Legislation 136

Legislation Hemp Patients Compliance 136

Cannabis Law Report

SEPTEMBER 22, 2022

SB 1186– Medicinal Cannabis Patients’ Right of Access Act. The bill’s author, Senator Scott Weiner, states this bill is a victory for seniors living with chronic illness, and will both improve patient access and help fill voids throughout the state where no cannabis license types have been authorized. FOOTNOTES. [1]

Law 52

Law Events Packaging Pets 52

Cannabis Law Report

AUGUST 4, 2021

from the second half of 2021 onwards as the Group fully repaid in May and June 2021 its 2022 and 2023 Eurobonds and successfully purchased a significant portion of its 2024 and 2026 Eurobonds which were bearing much higher interest rates. Objectives for FY 2023 also remain unchanged and do not include any COVID-19 impact either.

Business 105

Business Research and Development Environment Food 105

Cannabis Law Report

JULY 12, 2022

The listening sessions will each be two hours in length and focus on three topic areas: (1) Licensed premises, (2) Facilitator conduct, and (3) Client and product safety. Spanish interpretation, American Sign Language interpretation, and CART (Communication Access Realtime Translation) captioning services will be provided.

Programs 52

Programs Topical Education Safety 52

Cannabis Law Report

JUNE 11, 2019

Provide Canadians access to CBD, at appropriate dosages, for self-care in a manner consistent with their safety and low risk profile; 2. Support expansion of the Canadian hemp industry, including a 7 times increase in sales and jobs, by 2023. The current regulatory approach to CBD is perpetuating the illegal cannabis market.

Food 40

Food Hemp CBD Safety 40

Cannabis Law Report

DECEMBER 2, 2021

Recommendations and rulemaking relating to training and products were placed on an expedited timeline to ensure that facilitators will be trained, and products will be ready for the January 2, 2023, launch of the first state-sponsored psilocybin therapy program in the United States. Core Psilocybin Facilitation Skills (16 Hours).

Law 52

Law Programs Therapy Education 52

The Joint Blog

AUGUST 8, 2023

As of April 2023, 24 states, including Washington DC, have unintentionally legalized hemp-derived intoxicants, including delta-8 THC, by updating their controlled substance laws to reflect the changes in the 2018 farm bill. Despite its legality, there are concerns about the safety and regulation of delta-8 THC products.

Cannabinoids 26

Cannabinoids THC Packaging Safety 26

Cannabis Law Report

JUNE 18, 2021

The Connecticut Department of Consumer Protection (DCP) will create and enforce rules aimed at protecting public health and safety, preventing youth exposure, and avoiding diversion into the illegal market. All state tax revenue from adult-use sales will be directed to the state General Fund through June 30, 2023.

Legalization 66

Legalization Hybrid Cultivation Retail 66

Cannabis Law Report

JUNE 28, 2021

Merger includes retail, distribution and cultivation capabilities in the limited license market where adult-use sales are expected to reach up to US$230 million in 2023[1]. Retail sales in Vermont for adult-use cannabis products are expected to begin in the fall of 2022, with sales expected to reach up to US$230 million in 2023.

Retail 59

Retail Dispensary Packaging History 59

Cannabis Law Report

NOVEMBER 4, 2019

Demand for medicinal cannabis in Europe has reached new levels and is expected to grow by more than 400% through 2023. He has spent more than 10 years identifying and controlling safety risks, with expertise in addressing category issues like the prevention of mould and particulate contamination.

Hydroponic 49

Hydroponic Research and Development Environment Pharmaceutical 49